You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
FDA greenlights device to combat bladder issues
Overactive bladder can be a debilitating condition — but those affected now have a new treatment option. Last week, the FDA authorized a small ankle implant with an accompanying wearable that provides stimulation, both built by BlueWind Medical. The stimulation, called tibial neuromodulation, blocks abnormal nerve signals around the bladder.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect